Electrical safety products manufacturer Atkore (NYSE: ATKR) reported fourth-quarter revenue that surpassed Wall Street estimates, though sales remained unchanged year-over-year. Adjusted earnings significantly exceeded analyst projections, highlighting a mixed performance against a challenging industrial backdrop.
Gold and silver prices rebounded sharply in European trading Tuesday, recovering from a two-day plunge as fundamental demand drivers and attractive levels lured buyers back to the market.
Despite a modest year-to-date rebound, Conagra Brands' stock continues to trail the broader market significantly, with Wall Street analysts expressing caution over persistent industry headwinds and muted growth prospects.
Citi Research has initiated coverage on Sanofi with a Neutral rating and an €85 price target, citing pipeline setbacks and a lack of near-term catalysts. The analysis comes as the French pharma giant reports positive Phase 3 results for its eczema drug amlitelimab.
Goldman Sachs raises its price target for Energy Transfer LP (ET) to $19, citing the upcoming USAC/J-W Power deal and adjustments in NGL and crude oil segment forecasts, while maintaining a Neutral rating amid near-term EBITDA headwinds.
Keurig Dr Pepper has launched an $18 billion all-cash offer to acquire Dutch coffee giant JDE Peet's, a move set to reshape the global beverage landscape and split KDP into two separate public companies.
Elon Musk consolidates his space and AI ventures as SpaceX acquires xAI, with a combined valuation nearing $1.25 trillion. The move precedes a highly anticipated SpaceX IPO that could become the largest in history and reignite the global market for new listings.
Allstate (NYSE: ALL) sees renewed analyst confidence with multiple price target increases, driven by a significant drop in catastrophe losses and improved reinsurance costs. The insurer's financial resilience is in focus ahead of its Q4 2025 earnings call.
Mizuho Securities lowered its price target for Qualcomm, citing a weaker outlook for global smartphone shipments and increased competition. The firm projects a potential decline in handset production and pressures from rising memory costs.
Specialty materials maker ATI (NYSE: ATI) saw its shares surge after reporting fourth-quarter earnings that topped estimates, even as revenue came in slightly below Wall Street forecasts. The company pointed to strong demand in aerospace and defense as a key driver.
Electrical equipment maker Hubbell (NYSE:HUBB) reported fourth-quarter sales of $1.49 billion, aligning with Wall Street estimates, though underlying organic growth signals a moderation in demand.
In a strategic move to bridge traditional finance and digital assets, Deutsche Börse Group's 360T has partnered with Austrian crypto platform Bitpanda. The collaboration leverages Europe's new MiCA framework to offer institutional clients a compliant gateway into cryptocurrency trading and retail services.
Hamilton Lane (NASDAQ:HLNE) reported fourth-quarter revenue and profit that topped analyst estimates, fueled by robust growth in management fees and sustained demand for its private market expertise.
Industrial electronics giant AMETEK (NYSE:AME) delivered a strong top-line performance for the fourth quarter of 2025, surpassing revenue expectations with 13.4% year-over-year growth. However, a closer look reveals pressure on operating margins, painting a nuanced picture for the diversified manufacturer.
The maker of SuperPretzel and ICEE brands reported quarterly sales of $343.8 million, falling short of Wall Street forecasts and marking a year-over-year decline. Adjusted earnings also missed analyst expectations.
PJT Partners reported fourth-quarter revenue that fell short of analyst expectations, though earnings per share topped estimates and year-over-year sales growth remained robust at 12.1%, highlighting the advisory-focused bank's resilient performance in a challenging market.
Graphic Packaging Holding Company (NYSE: GPK) reported fourth-quarter 2025 sales that surpassed analyst expectations, yet flat year-over-year revenue and a significant earnings miss led to a sharp sell-off. The consumer packaging giant faces headwinds from competitive pressures and shifting consumer spending, prompting a strategic review by its CEO.
Merck & Co. reported solid fourth-quarter revenue growth driven by its blockbuster cancer drug Keytruda, but the pharmaceutical giant forecasts a slowdown in earnings growth as it absorbs billions in costs from recent acquisitions aimed at diversifying its pipeline ahead of Keytruda's patent expiration.
Ingredion (NYSE: INGR) reported fourth-quarter revenue of $1.76 billion, missing analyst expectations and marking a 2.4% year-over-year decline. Adjusted earnings per share also came in below consensus.
Gartner (NYSE:IT) reported fourth-quarter revenue in line with Wall Street forecasts at $1.75 billion, while earnings per share of $3.36 surpassed expectations. The research giant highlighted a major stock buyback and strategic divestiture, even as growth rates show signs of moderation.
